NCEL
NewcelX Ltd.
Key Financials
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| EFFECT | 9/22/2026 | View on SEC |
| POS AM | 9/18/2026 | View on SEC |
| 6-K | 9/18/2026 | View on SEC |
| EFFECT | 8/26/2026 | View on SEC |
| D | 8/24/2026 | View on SEC |
| F-3 | 8/20/2026 | View on SEC |
| 6-K | 8/3/2026 | View on SEC |
| 6-K | 7/31/2026 | View on SEC |
| 6-K | 7/15/2026 | View on SEC |
| 6-K | 7/8/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | NCEL |
| Company Name | NewcelX Ltd. |
| CIK | 1783036 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | other |
| Fiscal Year End | 1231 |
| State of Incorporation | V8 |
| Phone | 41-41-618-80-00 |